Regulatory News
Wednesday, March 30, 2016
BRIEF-Immunocellular Therapeutics reports loss per share of $0.05
* Immunocellular therapeutics announces 2015 financial
results
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment